| Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population H Korkaya, G Kim, A Davis, F Malik, NL Henry, S Ithimakin, AA Quraishi, ... Molecular cell 47 (4), 570-584, 2012 | 584 | 2012 |
| HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab S Ithimakin, KC Day, F Malik, Q Zen, SJ Dawsey, TF Bersano-Begey, ... Cancer research 73 (5), 1635-1646, 2013 | 276 | 2013 |
| Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activity RC D'Angelo, M Ouzounova, A Davis, D Choi, SM Tchuenkam, G Kim, ... Molecular cancer therapeutics 14 (3), 779-787, 2015 | 146 | 2015 |
| SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model G Kim, M Ouzounova, AA Quraishi, A Davis, N Tawakkol, SG Clouthier, ... Oncogene 34 (6), 671-680, 2015 | 95 | 2015 |
| Inactivation of p53/PTEN confers a specific epigenetic profile regulated by IL6-SOCS3 signaling M Ouzounova, G Kim, A Davis, AA Quraishi, N Tawakkol, S Kota, ... Cancer Research 74 (19_Supplement), 3866-3866, 2014 | 3 | 2014 |
| HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: Implications for efficacy of A Trastuzumab, S Ithimakin, KC Day, F Malik, Q Zen, SJ Dawsey, ... Cancer Research 73 (5), 1635-1646, 2013 | 3 | 2013 |
| HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab F Malik, S Ithimakin, K Day, K Ignatoski, Q Zen, D Thomas, T Bersano, ... Cancer Research 72 (8_Supplement), 3470-3470, 2012 | 1 | 2012 |
| IL6 feedback loop regulates breast cancer stem cells which mediate trastuzumab resistance. AL Davis, H Korkaya, M Ouzounova, F Malik, G Kim, AA Quraishi, S Liu, ... Cancer Research 73 (8_Supplement), 3736-3736, 2013 | | 2013 |
| Regulation of luminal breast cancer stem cells by HER2 does not require gene amplification providing a potential molecular explanation for the efficacy of adjuvant trastuzumab … K Hasan, F Malik, KC Day, S Ithimakin, A Davis, AA Quraishi, N Tawakkol, ... Cancer Research 73 (8_Supplement), 4065-4065, 2013 | | 2013 |
| Epigenetic regulation of cancer stem cell states in a p53/PTEN inactivated mammary epithelial cells. M Ouzounova, A Davis, G Kim, F Malik, AA Quraishi, SG Clouthier, ... Cancer Research 73 (8_Supplement), 5024-5024, 2013 | | 2013 |
| HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: Implications for efficacy of adjuvant trastuzumab F Maiik, S Ithimakin, K Day, K Ignatoski, Q Zen, D Thomas, T Bersano, ... CANCER RESEARCH 72, 2012 | | 2012 |
| Therapeutic targeting of the Notch pathway in breast cancer stem cells RC D'Angelo, H Korkaya, G Kim, A Davis, D Choi, T Luther, AA Quraishi, ... Cancer Research 71 (8_Supplement), 3352-3352, 2011 | | 2011 |
